A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
Authors
Keywords
-
Journal
mAbs
Volume 3, Issue 1, Pages 38-48
Publisher
Informa UK Limited
Online
2011-01-22
DOI
10.4161/mabs.3.1.14168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2
- (2010) Roni Mamluk et al. mAbs
- High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
- (2009) V. Ludovini et al. ANNALS OF ONCOLOGY
- Novel Agents on the Horizon for Cancer Therapy
- (2009) W. W. Ma et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
- (2009) A. Talavera et al. CANCER RESEARCH
- FN3: a new protein scaffold reaches the clinic
- (2009) Laird Bloom et al. DRUG DISCOVERY TODAY
- Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
- (2009) S. Kaulfuss et al. MOLECULAR CANCER THERAPEUTICS
- Biotech scientists bank on big pharma's biologics push
- (2009) Grace Wong NATURE BIOTECHNOLOGY
- Development trends for therapeutic antibody fragments
- (2009) Aaron L Nelson et al. NATURE BIOTECHNOLOGY
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
- (2009) John F. Flynn et al. Journal of Oncology
- Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
- (2008) Sergey M. Deyev et al. BIOESSAYS
- Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
- (2008) Y Akashi et al. BRITISH JOURNAL OF CANCER
- Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
- (2008) Judith Schmiedel et al. CANCER CELL
- Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors
- (2008) E. Buck et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started